{"id":"https://openalex.org/W4283318565","doi":"https://doi.org/10.1097/01.hs9.0000844888.58115.a4","title":"P500: A REAL WORLD MULTI CENTRE STUDY OF CPX-351 REVEALS NO DIFFERENCE IN OVERALL SURVIVAL WHEN COMPARED WITH FLAG-IDA AND 3 + 7 IN HIGH RISK AML.","display_name":"P500: A REAL WORLD MULTI CENTRE STUDY OF CPX-351 REVEALS NO DIFFERENCE IN OVERALL SURVIVAL WHEN COMPARED WITH FLAG-IDA AND 3 + 7 IN HIGH RISK AML.","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4283318565","doi":"https://doi.org/10.1097/01.hs9.0000844888.58115.a4"},"language":"en","primary_location":{"id":"doi:10.1097/01.hs9.0000844888.58115.a4","doi":"https://doi.org/10.1097/01.hs9.0000844888.58115.a4","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000844888.58115.a4","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1097/01.hs9.0000844888.58115.a4","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005710840","display_name":"Claire N Andrews","orcid":"https://orcid.org/0000-0002-8863-4301","observed_orcids":["https://orcid.org/0000-0002-8863-4301"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"C. Andrews","raw_affiliation_strings":["Division of Medical Haematology and Oncology, Princess Margaret Cancer Centre, Toronto"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Haematology and Oncology, Princess Margaret Cancer Centre, Toronto","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006025605","display_name":"Ibrahim Al Nabhani","orcid":"https://orcid.org/0000-0003-0230-625X","observed_orcids":["https://orcid.org/0000-0003-0230-625X"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"I. AlNabhani","raw_affiliation_strings":["Division of Medical Haematology and Oncology, Princess Margaret Cancer Centre, Toronto"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Haematology and Oncology, Princess Margaret Cancer Centre, Toronto","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":null,"display_name":"T. Young","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"T. Young","raw_affiliation_strings":["Division of Medical Haematology and Oncology, Princess Margaret Cancer Centre, Toronto"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Haematology and Oncology, Princess Margaret Cancer Centre, Toronto","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057593975","display_name":"Eshetu G. Atenafu","orcid":"https://orcid.org/0000-0002-4613-3680","observed_orcids":["https://orcid.org/0000-0002-4613-3680"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"E. G. Atenafu","raw_affiliation_strings":["Division of Medical Haematology and Oncology, Princess Margaret Cancer Centre, Toronto"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Haematology and Oncology, Princess Margaret Cancer Centre, Toronto","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109602188","display_name":"Sarit E. Assouline","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"S. E. Assouline","raw_affiliation_strings":["Division of Hematology, Sir Mortimer B. Davis-Jewish General Hospital, Montreal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Sir Mortimer B. Davis-Jewish General Hospital, Montreal","institution_ids":["https://openalex.org/I2801824472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034085838","display_name":"Joseph M. Brandwein","orcid":"https://orcid.org/0000-0001-9095-8789","observed_orcids":["https://orcid.org/0000-0001-9095-8789"]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"J. M. Brandwein","raw_affiliation_strings":["Division of Hematology, University of Alberta, Edmonton"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, University of Alberta, Edmonton","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059745705","display_name":"Steven M. Chan","orcid":"https://orcid.org/0000-0002-4354-0731","observed_orcids":["https://orcid.org/0000-0002-4354-0731"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"S. M. Chan","raw_affiliation_strings":["Division of Medical Haematology and Oncology, Princess Margaret Cancer Centre, Toronto"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Haematology and Oncology, Princess Margaret Cancer Centre, Toronto","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086571729","display_name":"Signy Chow","orcid":"https://orcid.org/0000-0002-6303-1774","observed_orcids":["https://orcid.org/0000-0002-6303-1774"]},"institutions":[{"id":"https://openalex.org/I1323843004","display_name":"Sunnybrook Health Science Centre","ror":"https://ror.org/03wefcv03","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004"]},{"id":"https://openalex.org/I4405271711","display_name":"Odette Cancer Centre","ror":"https://ror.org/02ww1s787","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004","https://openalex.org/I4405271711"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"S. Chow","raw_affiliation_strings":["Odette Cancer Centre, Sunnybrook Health Science Centre, Toronto"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Odette Cancer Centre, Sunnybrook Health Science Centre, Toronto","institution_ids":["https://openalex.org/I1323843004","https://openalex.org/I4405271711"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044016966","display_name":"Dina Khalaf","orcid":"https://orcid.org/0000-0002-2119-6626","observed_orcids":["https://orcid.org/0000-0002-2119-6626"]},"institutions":[{"id":"https://openalex.org/I2799698466","display_name":"Juravinski Cancer Centre","ror":"https://ror.org/02cwjh447","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2799698466","https://openalex.org/I76442945"]},{"id":"https://openalex.org/I98251732","display_name":"McMaster University","ror":"https://ror.org/02fa3aq29","country_code":"CA","type":"education","lineage":["https://openalex.org/I98251732"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"D. Khalaf","raw_affiliation_strings":["Division of Hematology, Juravinski Cancer Centre, McMaster University, Hamilton"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Juravinski Cancer Centre, McMaster University, Hamilton","institution_ids":["https://openalex.org/I2799698466","https://openalex.org/I98251732"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067214379","display_name":"Vikas K Gupta","orcid":"https://orcid.org/0000-0002-1419-8607","observed_orcids":["https://orcid.org/0000-0002-1419-8607"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"V. Gupta","raw_affiliation_strings":["Division of Medical Haematology and Oncology, Princess Margaret Cancer Centre, Toronto"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Haematology and Oncology, Princess Margaret Cancer Centre, Toronto","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084708084","display_name":"Dennis Dong Hwan Kim","orcid":"https://orcid.org/0000-0003-2640-4911","observed_orcids":["https://orcid.org/0000-0003-2640-4911","https://orcid.org/0000-0002-0708-9242","https://orcid.org/0000-0002-0998-1090"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"D. D. H. Kim","raw_affiliation_strings":["Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, Toronto"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, Toronto","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085305707","display_name":"Dawn C. Maze","orcid":"https://orcid.org/0000-0002-4598-9380","observed_orcids":["https://orcid.org/0000-0002-4598-9380"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"D. Maze","raw_affiliation_strings":["Division of Medical Haematology and Oncology, Princess Margaret Cancer Centre, Toronto"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Haematology and Oncology, Princess Margaret Cancer Centre, Toronto","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040203542","display_name":"Mark Minden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"M. M. Minden","raw_affiliation_strings":["Division of Medical Haematology and Oncology, Princess Margaret Cancer Centre, Toronto"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Haematology and Oncology, Princess Margaret Cancer Centre, Toronto","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037110889","display_name":"Tracy Murphy","orcid":"https://orcid.org/0000-0001-5198-0406","observed_orcids":["https://orcid.org/0000-0001-5198-0406"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"T. Murphy","raw_affiliation_strings":["Division of Medical Haematology and Oncology, Princess Margaret Cancer Centre, Toronto"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Haematology and Oncology, Princess Margaret Cancer Centre, Toronto","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112843154","display_name":"David Sanford","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"D. Sanford","raw_affiliation_strings":["Leukemia/Bone Marrow Transplant Program of British Columbia, University of British Columbia, Vancouver, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia/Bone Marrow Transplant Program of British Columbia, University of British Columbia, Vancouver, Canada","institution_ids":["https://openalex.org/I141945490"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045250493","display_name":"Aaron David Schimmer","orcid":"https://orcid.org/0000-0003-4023-3899","observed_orcids":["https://orcid.org/0000-0003-4023-3899"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"A. D. Schimmer","raw_affiliation_strings":["Division of Medical Haematology and Oncology, Princess Margaret Cancer Centre, Toronto"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Haematology and Oncology, Princess Margaret Cancer Centre, Toronto","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002489867","display_name":"Andre C. Schuh","orcid":"https://orcid.org/0000-0003-2869-852X","observed_orcids":["https://orcid.org/0000-0003-2869-852X"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"A. C. Schuh","raw_affiliation_strings":["Division of Medical Haematology and Oncology, Princess Margaret Cancer Centre, Toronto"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Haematology and Oncology, Princess Margaret Cancer Centre, Toronto","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089155030","display_name":"Jad Sibai","orcid":"https://orcid.org/0000-0002-2399-6272","observed_orcids":["https://orcid.org/0000-0002-2399-6272"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"J. Sibai","raw_affiliation_strings":["Division of Medical Haematology and Oncology, Princess Margaret Cancer Centre, Toronto"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Haematology and Oncology, Princess Margaret Cancer Centre, Toronto","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055906478","display_name":"Karen W L Yee","orcid":"https://orcid.org/0000-0002-2572-9952","observed_orcids":["https://orcid.org/0000-0002-2572-9952"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"K. Yee","raw_affiliation_strings":["Division of Medical Haematology and Oncology, Princess Margaret Cancer Centre, Toronto"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Haematology and Oncology, Princess Margaret Cancer Centre, Toronto","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048157762","display_name":"Hassan Abdulmaoula Sibai","orcid":"https://orcid.org/0000-0001-9030-8583","observed_orcids":["https://orcid.org/0000-0001-9030-8583"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"H. Sibai","raw_affiliation_strings":["Division of Medical Haematology and Oncology, Princess Margaret Cancer Centre, Toronto"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Haematology and Oncology, Princess Margaret Cancer Centre, Toronto","institution_ids":["https://openalex.org/I2802654988"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5005710840"],"corresponding_institution_ids":["https://openalex.org/I2802654988"],"apc_list":{"value":2480,"currency":"USD","value_usd":2480},"apc_paid":{"value":2480,"currency":"USD","value_usd":2480},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.08851399,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":null,"first_page":"399","last_page":"400"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cpx-351","display_name":"CPX-351","score":0.9929999709129333},{"id":"https://openalex.org/keywords/high-risk-acute-myeloid-leukemia","display_name":"high-risk acute myeloid leukemia","score":0.8989999890327454},{"id":"https://openalex.org/keywords/therapy-related-myeloid-neoplasms","display_name":"therapy-related myeloid neoplasms","score":0.8140000104904175},{"id":"https://openalex.org/keywords/flag-ida","display_name":"FLAG-IDA","score":0.8920000195503235},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7559999823570251},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8830000162124634},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.7369999885559082},{"id":"https://openalex.org/keywords/runx1-mutation","display_name":"RUNX1 mutation","score":0.6899999976158142},{"id":"https://openalex.org/keywords/asxl1-mutation","display_name":"ASXL1 mutation","score":0.9819999933242798},{"id":"https://openalex.org/keywords/srsf2-mutation","display_name":"SRSF2 mutation","score":0.9860000014305115},{"id":"https://openalex.org/keywords/real-world-outcomes","display_name":"real-world outcomes","score":0.6470000147819519},{"id":"https://openalex.org/keywords/targeted-sequencing","display_name":"targeted sequencing","score":0.4729999899864197}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7424279451370239},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.612932026386261},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5915953516960144},{"id":"https://openalex.org/C2776730729","wikidata":"https://www.wikidata.org/wiki/Q1392130","display_name":"Flag (linear algebra)","level":3,"score":0.5904752612113953},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.5392327308654785},{"id":"https://openalex.org/C2781021840","wikidata":"https://www.wikidata.org/wiki/Q411659","display_name":"Daunorubicin","level":3,"score":0.4469543695449829},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.35196489095687866},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.26320716738700867},{"id":"https://openalex.org/C136119220","wikidata":"https://www.wikidata.org/wiki/Q1000660","display_name":"Algebra over a field","level":2,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C202444582","wikidata":"https://www.wikidata.org/wiki/Q837863","display_name":"Pure mathematics","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1097/01.hs9.0000844888.58115.a4","doi":"https://doi.org/10.1097/01.hs9.0000844888.58115.a4","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000844888.58115.a4","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:2065249a240b4c34b38529fa36faa349","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/2065249a240b4c34b38529fa36faa349","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"HemaSphere, Vol 6, Pp 399-400 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1097/01.hs9.0000844888.58115.a4","doi":"https://doi.org/10.1097/01.hs9.0000844888.58115.a4","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000844888.58115.a4","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.5600000023841858}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3095490154","https://openalex.org/W4405045315","https://openalex.org/W4405043236","https://openalex.org/W3120624848","https://openalex.org/W4417019837","https://openalex.org/W4389232182","https://openalex.org/W4376224778","https://openalex.org/W4405039859","https://openalex.org/W7018924292","https://openalex.org/W2986735574"],"abstract_inverted_index":{"Background:":[0],"CPX-351":[1,50,61,87,201,384,434,472],"is":[2,46,56,65,540,582],"a":[3,11,52,258,263,361,425,498,517,577],"liposomal":[4],"formulation":[5],"of":[6,15,49,78,86,217,224,255,347,349,363,398,404,430,503,505,519,525,571],"daunorubicin":[7],"and":[8,25,37,88,98,106,112,120,128,164,184,220,246,296,307,377,386,402,443,457,475],"cytarabine":[9],"in":[10,29,51,67,93,132,236,243,248,316,394,468,487,549],"fixed":[12],"synergistic":[13],"ratio":[14],"5:1.":[16],"It":[17],"has":[18],"been":[19],"approved":[20],"by":[21,240,320,542],"both":[22],"the":[23,123,133,176,193,221,230,380],"FDA":[24],"EMA":[26],"for":[27,72,102,126,144,157,379,455,459],"use":[28],"high-risk":[30,73],"AML":[31,35,38,74,533],"including":[32],"therapy":[33],"related":[34,41],"(t-AML)":[36],"with":[39,117,162,200,204,266,419,422,439,441,445,555,576],"myelodysplastic":[40],"change":[42],"(AML-MRC).":[43],"However,":[44],"this":[45],"little":[47],"data":[48,59,136,156],"real-world":[53],"setting.":[54],"There":[55,312,463],"also":[57],"no":[58,314,465,485,547],"comparing":[60,471,490],"to":[62,83,154,287,355,436,473,511],"FLAG-IDA":[63,97,163,378,401,442,456,474,558],"which":[64,539,545],"used":[66,153],"our":[68,79,543],"institution":[69],"front":[70],"line":[71],"Aims:":[75],"The":[76,146,270],"objective":[77],"multi-centre":[80],"study":[81,544,575],"was":[82,137,152,170,213,226,229,274,282,291,302,453,464,484,528],"assess":[84],"outcomes":[85,92],"then":[89],"compare":[90],"these":[91],"patients":[94,158,198,218,256,399,431,569],"who":[95,114,121,159,340,357,372,432,496,513],"received":[96,160,341,373,433,497],"3":[99,165,374,407,446,460,476,492,560],"+":[100,166,375,408,447,461,477,561],"7":[101,376,409,478],"high":[103],"risk":[104,322,325,330,413,532],"AML(tAML":[105],"AML-MRC).":[107],"Methods:":[108],"Patients":[109,371,495],"aged":[110],"18":[111,299,310,352,366,451,508,522],"over":[113],"were":[115,130,190,202,313,388,417],"treated":[116,199,554],"induction":[118,161,527,572],"chemotherapy":[119],"met":[122],"WHO":[124],"criteria":[125],"t-AML":[127],"AML-MRC":[129],"included":[131],"study.":[134],"Retrospective":[135],"collected":[138],"from":[139],"10":[140],"centres":[141],"throughout":[142],"Canada":[143],"CPX-351.":[145],"Princess":[147],"Margaret":[148],"Cancer":[149],"Centre":[150],"database":[151],"collect":[155],"7.":[167,448,462,562],"Targeted":[168,211],"sequencing":[169,212],"performed":[171,214],"on":[172,208,215],"DNA":[173],"samples":[174],"using":[175,192],"TruSight":[177],"Myeloid":[178],"Sequencing":[179],"Panel.":[180],"Overall":[181],"survival":[182,187],"(OS)":[183],"progression":[185],"free":[186],"(PFS)":[188],"rates":[189,416],"calculated":[191],"Kaplan-Meier":[194],"method.":[195],"Results:":[196],"76":[197],"identified":[203],"baseline":[205],"characteristics":[206,391],"seen":[207],"Table":[209,395],"1.":[210,396],"72%":[216],"(55/76)":[219],"average":[222],"number":[223],"mutations":[225,331],"2(0-7).":[227],"RUNX1":[228,334],"most":[231],"commonly":[232],"mutated":[233,242],"gene":[234],"found":[235],"22%":[237],"(12/55),":[238],"followed":[239],"ASXL1":[241,336],"19%":[244],"(10/55)":[245],"SRSF2":[247],"15%.":[249],"Assessing":[250],"treatment":[251],"responses,":[252],"53%":[253],"(38/76)":[254],"achieved":[257],"complete":[259,264],"remission":[260,265],"(CR)":[261],"or":[262,328,338,427,551,559],"incomplete":[267],"recovery":[268],"(CRi).":[269],"median":[271],"CR":[272,415,426],"duration":[273],"short":[275],"at":[276,293,298,304,309,351,365,450,507,521],"7.3":[277],"months.":[278,300,311],"Median":[279],"follow":[280],"up":[281],"7.78":[283],"months":[284,295,306,353,367,452,509,523],"(range":[285],"0.2":[286],"20":[288],"months).":[289],"OS":[290,317,348,449,469,504,550,566],"57%":[292,444],"12":[294,305],"38%":[297],"PFS":[301,488,552],"40%":[303],"23%":[308],"differences":[315],"when":[318,470,489,553],"stratified":[319],"ELN":[321,412],"(p=0.46),":[323],"adverse":[324,411],"cytogenetics":[326],"(p=0.1485),":[327],"poor":[329],"such":[332],"as":[333,383],"(p=0.73),":[335],"(p=0.47)":[337],"TP53(p=0.53).Patients":[339],"an":[342,535],"ASCT":[343,437,499,564],"had":[344,410,500],"significant":[345,501],"improvement":[346,502],"82%":[350],"compared":[354,438,510],"those":[356,405,512],"did":[358,514],"not":[359,515],"receive":[360,516],"transplant":[362,518],"15%":[364],"(Fig":[368],"2;":[369],"p=0.0001).":[370],"same":[381],"indications":[382],"(tAML":[385],"AML-MRC)":[387],"identified.":[389],"Baseline":[390],"are":[392],"shown":[393],"69%":[397],"receiving":[400,406],"67%":[403],"stratification.":[414],"highest":[418],"FLAG":[420],"IDA":[421],"75%":[423],"achieving":[424],"CRi.":[428],"68%":[429],"proceeded":[435],"59%":[440,506],"42%":[454],"39%":[458],"statistical":[466],"difference":[467,486,548],"(p=0.855)":[479],"(Figure":[480],"1).":[481],"Similarly,":[482],"there":[483],"all":[491,568],"inductions":[493],"(p=0.26).":[494],"24%":[520],"(p=<0.0001)irrespective":[524],"what":[526],"used.":[529],"Image:Summary/Conclusion:":[530],"High":[531],"remains":[534],"unmet":[536],"clinical":[537],"need":[538],"supported":[541],"reveals":[546],"either":[556],"CPX-351,":[557],"Unsurprisingly,":[563],"improved":[565],"across":[567],"irrespective":[570],"type.":[573],"Further":[574],"prospective":[578],"randomised":[579],"control":[580],"trial":[581],"required.":[583]},"counts_by_year":[],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2022-06-24T00:00:00"}